May 05, 2025
1:14
For every 14 shares held, investors received 1. The price per share adjusted from $0.20 to $0.01.
The split itself did not change the total investment value.
Protagenic Therapeutics, Inc. (PTIX) trades on the Other OTC in the Biotechnology industry.
Protagenic Therapeutics, Inc. company overviewThe latest split shown was on May 5, 2025. It was a 1-for-14 reverse split, so shareholders received 1 share for every 14 they held.
This history records 6 reverse splits between May 3, 2007 and May 5, 2025.